Home > Insider Trading > Filing (0001181431-11-025659)

Filing Details

Accession Number:: 0001181431-11-025659
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-04-27 18:04:53
Reporting Period:: 2011-04-27

Filing Date:: 2011-04-27
Accepted Time:: 2011-04-27 18:04:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1123494	Harvard Bioscience Inc	HBIO	Laboratory Analytical Instruments (3826)	043306140

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1008643	David Green	84 October Hill Road Holliston MA 01746	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-04-25	11,556	$5.96	1,466,346	No	4	S	Direct
Common Stock	Disposition	2011-04-26	2,944	$5.97	1,463,402	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares sold by Mr. Green pursuant to a Sales Plan under Rule 10b5-1 adopted by the reporting person in September 2009.
Reflects the weighted average price of the shares sold in the reported transaction. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.00, inclusive. The reporting person undertakes to provide to Harvard Bioscience, Inc., any security holder of Harvard Bioscience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Reflects the weighted average price of the shares sold in the reported transaction. These shares were sold in multiple transactions at prices ranging from $5.95 to $5.98, inclusive. The reporting person undertakes to provide to Harvard Bioscience, Inc., any security holder of Harvard Bioscience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Includes (a) a deferred stock award of 100,200 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013 and January 1, 2014; and (b) 1,366,146 shares of common stock held by Mr. Green.
Includes (a) a deferred stock award of 100,200 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013 and January 1, 2014; and (b) 1,363,202 shares of common stock held by Mr. Green.